Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CRISPR Therapeutics AG | Director | Common Shares | 769,196 | $55 M | $71.50 | Feb 27, 2024 | Indirect |
Nkarta, Inc. | Director | Common Stock | 451,659 | $4.52 M | $10.00 | Mar 27, 2024 | Indirect |
Nkarta, Inc. | Director | Stock Option (right to buy) | 22,500 | Jun 13, 2024 | Direct | ||
Design Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 19,000 | Jun 13, 2024 | Direct | ||
CRISPR Therapeutics AG | Director | Stock Option (Right to buy) | 13,000 | May 30, 2024 | Direct | ||
Turning Point Therapeutics, Inc. | Director | Common Stock | 0 | $76.00 | Aug 17, 2022 | Indirect | |
Turning Point Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DSGN | Design Therapeutics, Inc. | Jun 13, 2024 | 1 | 0 | 4 | Jun 17, 2024 | Director, 10%+ Owner |
NKTX | Nkarta, Inc. | Jun 13, 2024 | 1 | 0 | 4 | Jun 14, 2024 | Director |
CRSP | CRISPR Therapeutics AG | May 30, 2024 | 1 | 0 | 4 | May 31, 2024 | Director |
NKTX | Nkarta, Inc. | Mar 27, 2024 | 2 | 20,000,000 | 4 | Mar 28, 2024 | Director |
CRSP | CRISPR Therapeutics AG | Feb 27, 2024 | 3 | 74,999,997 | 4 | Feb 27, 2024 | Director |
CRSP | CRISPR Therapeutics AG | Jun 8, 2023 | 1 | 0 | 4 | Jun 9, 2023 | Director |
NKTX | Nkarta, Inc. | Jun 7, 2023 | 1 | 0 | 4 | Jun 9, 2023 | Director |
DSGN | Design Therapeutics, Inc. | May 31, 2023 | 1 | 0 | 4 | Jun 2, 2023 | Director, 10%+ Owner |
DSGN | Design Therapeutics, Inc. | Dec 16, 2022 | 3 | 7,574,078 | 4 | Dec 20, 2022 | Director, 10%+ Owner |
TPTX | Turning Point Therapeutics, Inc. | Aug 17, 2022 | 4 | -171,278,160 | 4 | Aug 17, 2022 | Director |
DSGN | Design Therapeutics, Inc. | Jun 15, 2022 | 1 | 0 | 4 | Jun 16, 2022 | Director, 10%+ Owner |
CRSP | CRISPR Therapeutics AG | Jun 9, 2022 | 1 | 0 | 4 | Jun 10, 2022 | Director |
NKTX | Nkarta, Inc. | Jun 8, 2022 | 1 | 0 | 4 | Jun 10, 2022 | Director |
NKTX | Nkarta, Inc. | Apr 28, 2022 | 2 | 19,999,995 | 4 | Apr 29, 2022 | Director |
NKTX | Nkarta, Inc. | Jun 13, 2021 | 1 | 0 | 4 | Jun 15, 2021 | Director |
CRSP | CRISPR Therapeutics AG | Jun 10, 2021 | 1 | 0 | 4 | Jun 14, 2021 | Director |
TPTX | Turning Point Therapeutics, Inc. | Jun 2, 2021 | 1 | 0 | 4 | Jun 4, 2021 | Director |